Thailand’s Chulalongkorn University is seeking approval from the Thai Food and Drug Administration (TFDA) to begin the first two phases of human trials of its mRNA COVID-19 vaccine. According to the “Thai Roo Soo COVID” Facebook page the vaccine, called ChulaCov19, is the first mRNA vaccine developed in Thailand. During the initial stage of development, … Continue reading Chulalongkorn University’s COVID mRNA vaccine to enter human trials